Skip to main content

Month: March 2020

Niu Technologies Announces Fourth Quarter and Full Year 2019 Financial Results

— Fourth Quarter Total volume of e-scooter sales up 13.5% year over year— Fourth Quarter Revenues of RMB 536.1 million, up 25.4% year over year— Fourth Quarter Net income of RMB 60.7 million, compared to net loss of RMB 32.0 million in the fourth quarter of last year— Full Year Total volume of e-scooter sales up 24.1% year over year— Full Year Revenues of RMB 2,076.3 million, up 40.5% year over year— Full Year Net income of RMB 190.1 million, compared to net loss of RMB 349.0 million in 2018BEIJING, March 16, 2020 (GLOBE NEWSWIRE) — Niu Technologies (“Niu”, or “the Company”) (NASDAQ: NIU), the world’s leading provider of smart urban mobility solutions, today announced its financial results for the fourth quarter and full year ended December 31, 2019.Fourth Quarter 2019 Financial HighlightsRevenues...

Continue reading

FCA Responds to COVID-19 Emergency in Europe

FCA Responds to COVID-19 Emergency in EuropeFiat Chrysler Automobiles N.V. (NYSE: FCAU / MTA: FCA) (“FCA”) announced today that its subsidiaries FCA Italy and Maserati will temporarily suspend production across the majority of their European manufacturing plants.The temporary suspension, which will be in effect through March 27, 2020, continues the implementation of a comprehensive set of actions in response to the COVID-19 emergency and enables the Group to effectively respond to the interruption in market demand by ensuring the optimization of supply.  In particular, the suspension of production is being facilitated to enable the Group to be ready to commence production promptly once market conditions allow.The updated production plan will temporarily close the following facilities with effect for the month of March:Italy: Melfi, G....

Continue reading

Wereldhave: Update on Corona-virus impact

Press release | Update on Corona-virus impactThe situation regarding the outbreak in Europe of COVID-19 (‘Corona-virus’) is having an unprecedented impact on the business in our shopping centers.In Belgium it was announced on March 13, 2020 that non-essential stores are closed during the weekends, for now until April 3, 2020. In France, starting March 15, 2020, all non-essential stores are closed throughout the country. In the Netherlands, the F&B sector has been closed down as from March 15, 2020. For other retailers no official restrictions have been put in place as of yet, but we do recognize significant risks to the operations of these retailers.These circumstances will not waive any contractual rental obligations unless otherwise directed by local law or regulations. However, Wereldhave will determine on a case-by-case basis...

Continue reading

Notice of Change to TGS Financial Calendar

Asker, Norway (16 March 2020) – The 2020 TGS financial calendar is revised to reflect these changes:13 April 2020 – Annual ReportThis information is published pursuant to the requirements set out in the continuing obligations.About TGSTGS provides multi-client geoscience data to oil and gas Exploration and Production companies worldwide. In addition to extensive global geophysical and geological data libraries that include multi-client seismic data, magnetic and gravity data, digital well logs, production data and directional surveys, TGS also offers advanced processing and imaging services, interpretation products, and data integration solutions.Forward Looking StatementAll statements in this press release other than statements of historical fact are forward-looking statements, which are subject to a number of risks, uncertainties and...

Continue reading

ERYTECH Announces the Appointment of Dr. Melanie Rolli to its Board of Directors

LYON, France and CAMBRIDGE, Mass. , March 16, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced the appointment of Melanie Rolli, M.D.,  to its Board of Directors and the intention to propose the ratification of her appointment at ERYTECH’s next General Meeting of Shareholders. Dr. Rolli has more than 15 years of experience in the global biopharmaceutical and biotechnology industry, including in both Europe and the United States. Dr. Rolli’s appointment follows the resignation of Allene Diaz, who resigned from the Board effective September 30, 2019.“We are very pleased to welcome Melanie to our Board of Directors,” commented Dr Jean-Paul Kress, Chairman...

Continue reading

Unibail-Rodamco-Westfield provides market update on the impact of COVID-19

Paris, Amsterdam, March 16, 2020Press releaseUnibail-Rodamco-Westfield provides market update on the impact of COVID-19The COVID-19 crisis continues to evolve rapidly and in recent days several governments in the markets in which Unibail-Rodamco-Westfield (“URW”) operates have taken measures to contain the spread of the virus. These measures will impact the Group’s operations.URW’s primary focus is now on protecting the health and safety of its employees, tenants, and visitors, and the Group is carefully monitoring the latest health guidelines issued by the World Health Organization, national, regional, and local governments and adapting its operations accordingly.At this date, local authorities have required all non-essential stores to close in France, Spain, Poland, Austria, the Czech Republic and Slovakia. As such, the Group’s shopping...

Continue reading

ERYTECH annonce la nomination du Dr. Melanie Rolli au Conseil d’administration

LYON, France, 16 mars 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Euronext Paris et Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant des médicaments dans les globules rouges, annonce aujourd’hui la cooptation de Melanie Rolli, MD, à son Conseil d’administration, et l’intention de proposer la ratification de sa nomination lors de la prochaine Assemblée Générale. Le Dr. Rolli a plus de 15 ans d’expérience dans l’industrie biopharmaceutique et biotechnologique mondiale, tant en Europe qu’aux États-Unis. La nomination du Dr. Melanie Rolli fait suite à la démission d’Allene Diaz du Conseil d’administration, avec date d’effet le 30 septembre 2019.« Nous sommes très heureux d’accueillir Melanie au sein de notre Conseil d’administration »,...

Continue reading

Aéroports de Paris SA: Coronavirus Groupe ADP engages an operational and financial optimization plan

PRESS RELEASE16 March 2020Aéroports de Paris SACoronavirus: Groupe ADP engages an operational and financial optimization planAs foreshadowed in the press release published on this day regarding February 2020 traffic, Groupe ADP traffic1 is, since the beginning of this leap year, stable with a total of 31.9 million of passengers on the first two months of the year (compared to the first two months of 2019). Paris Aéroport traffic is for its part up by 0.8% on this period with a total of 15.2 million passengers. At the end of February, the impact of the CoVid 19 outbreak on traffic thus remained limited but was amplifying in Paris and on certain platforms abroad. Between the 1st and the 14th of March2, the estimated drop in passenger traffic and aircraft movements has accelerated on Parisian platforms with an estimated evolution of -29%...

Continue reading

Aéroports de Paris SA : Coronavirus Groupe ADP engages an operational and financial optimization plan

COMMUNIQUE DE PRESSETremblay-en-France, le 16 mars 2020Aéroports de Paris SACoronavirus : le Groupe ADP engage un plan d’optimisation opérationnel et financierAinsi qu’annoncé dans le communiqué de presse publié ce jour relatif au trafic du mois de février 2020, le trafic du Groupe ADP1 est, depuis le début de cette année bissextile, stable avec un total de 31,9 millions de passagers sur les 2 premiers mois de l’année (par rapport aux 2 premiers mois de l’année 2019). Le trafic de Paris Aéroport est pour sa part en progression sur cette période de 0,8 %, avec un total de 15,2 millions de passagers. A fin février, l’impact de l’épidémie de CoVid 19 sur le trafic restait donc mesuré mais s’amplifiait à Paris et sur certaines plates-formes du groupe à l’international. Entre le 1er et le 14 mars2,...

Continue reading

Aktia tarjoaa koronavirustilanteen helpottamiseksi lyhennysvapaata henkilö- ja yritysasiakkaille

Koronaviruksen nopea leviäminen ja sen aiheuttamat taloudelliset vaikutukset niin yksilöille ja yrityksille kuin koko Suomelle aiheuttavat nyt huolta. Aktia haluaa osaltaan kantaa kortensa kekoon tilanteen helpottamiseksi ja tarjoaa henkilö- ja yritysasiakkailleen kahdeksan kuukautta lyhennysvapaata.”Koronakriisin aiheuttama maailmantalouden tilanne on tällä hetkellä vakava, ja siitä johtuva epävarmuus huolettaa meitä kaikkia. Me haluamme tässä vaikeassa tilanteessa kantaa oman yhteiskuntavastuumme ja olla asiakkaidemme tukena. Suomi on Aktian ja sen edeltäjien kaksisataavuotisen historian aikana kansakuntana selvinnyt monista vaikeista ajoista. Ei ole epäilystäkään, ettemmekö selviäisi yhdessä myös tästä”, sanoo Aktian toimitusjohtaja Mikko Ayub.  Lyhennysvapaasta kiinnostuneille henkilö- ja yritysasiakkaille löytyy asiasta lisää tietoa...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.